Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,800 | -170,600 | -115,200 | -28,900 | -20,600 |
| Depreciation Amortization | 151,700 | 134,000 | 116,300 | 37,700 | 18,200 |
| Income taxes - deferred | -600 | -49,000 | -16,000 | -6,800 | -5,100 |
| Accounts receivable | 33,300 | 50,300 | 15,900 | 13,600 | 16,700 |
| Accounts payable and accrued liabilities | -2,600 | 600 | 9,200 | -11,300 | -9,300 |
| Other Working Capital | -15,000 | 119,800 | 25,700 | -5,400 | 10,200 |
| Other Operating Activity | 6,500 | -38,300 | -19,100 | 15,000 | 5,700 |
| Operating Cash Flow | $-12,500 | $46,800 | $16,800 | $13,900 | $15,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,800 | -5,300 | -3,000 | -4,800 | -1,400 |
| Net Acquisitions | 21,300 | 21,300 | 21,300 | N/A | N/A |
| Purchase Of Investment | -15,800 | -15,800 | -15,800 | -45,000 | -23,100 |
| Sale Of Investment | 51,900 | 33,400 | 20,700 | 35,500 | 17,400 |
| Investing Cash Flow | $50,600 | $33,600 | $23,200 | $-14,300 | $-7,100 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | N/A | N/A | -8,600 | -8,600 |
| Common Stock Issued | 2,200 | 2,200 | 300 | 1,300 | -400 |
| Other Financing Activity | -5,000 | -1,100 | -100 | -3,900 | -3,300 |
| Financing Cash Flow | $-2,800 | $1,100 | $200 | $-11,200 | $-12,300 |
| Exchange Rate Effect | 300 | -500 | -1,900 | 1,100 | 300 |
| Beginning Cash Position | 81,200 | 81,200 | 81,200 | 93,200 | 93,200 |
| End Cash Position | 118,300 | 163,700 | 121,000 | 81,200 | 89,900 |
| Net Cash Flow | $37,100 | $82,500 | $39,800 | $-12,000 | $-3,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,500 | 46,800 | 16,800 | 13,900 | 15,800 |
| Capital Expenditure | -6,800 | -5,300 | -3,000 | -4,800 | -1,400 |
| Free Cash Flow | -19,300 | 41,500 | 13,800 | 9,100 | 14,400 |